1. Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment. Issue 12 (30th August 2018) Authors: Javier Escalada, F.; Halimi, Serge; Senior, Peter A.; Bonnemaire, Mireille; Cali, Anna M. G.; Melas‐Melt, Lydie; Karalliedde, Janaka; Ritzel, Robert A. Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 12(2018) Page Start: 2860 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗